Compare Abbott India with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs DIVIS LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA DIVIS LABORATORIES ABBOTT INDIA/
DIVIS LABORATORIES
 
P/E (TTM) x 50.3 51.9 96.8% View Chart
P/BV x 14.1 11.9 118.2% View Chart
Dividend Yield % 1.6 0.5 338.3%  

Financials

 ABBOTT INDIA   DIVIS LABORATORIES
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-21
DIVIS LABORATORIES
Mar-21
ABBOTT INDIA/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs18,5693,913 474.5%   
Low Rs13,9701,824 765.8%   
Sales per share (Unadj.) Rs2,028.2262.5 772.6%  
Earnings per share (Unadj.) Rs325.074.7 434.8%  
Cash flow per share (Unadj.) Rs352.484.4 417.6%  
Dividends per share (Unadj.) Rs275.0020.00 1,375.0%  
Avg Dividend yield %1.70.7 242.4%  
Book value per share (Unadj.) Rs1,203.7350.1 343.8%  
Shares outstanding (eoy) m21.25265.47 8.0%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x8.010.9 73.4%   
Avg P/E ratio x50.138.4 130.4%  
P/CF ratio (eoy) x46.234.0 135.8%  
Price / Book Value ratio x13.58.2 165.0%  
Dividend payout %84.626.8 316.2%   
Avg Mkt Cap Rs m345,717761,517 45.4%   
No. of employees `000NANA-   
Total wages/salary Rs m4,9278,258 59.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m43,10069,694 61.8%  
Other income Rs m835627 133.2%   
Total revenues Rs m43,93570,321 62.5%   
Gross profit Rs m9,18928,611 32.1%  
Depreciation Rs m5812,556 22.7%   
Interest Rs m18321 870.5%   
Profit before tax Rs m9,26026,660 34.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,3536,818 34.5%   
Profit after tax Rs m6,90719,843 34.8%  
Gross profit margin %21.341.1 51.9%  
Effective tax rate %25.425.6 99.4%   
Net profit margin %16.028.5 56.3%  
BALANCE SHEET DATA
Current assets Rs m35,18567,906 51.8%   
Current liabilities Rs m10,30917,284 59.6%   
Net working cap to sales %57.772.6 79.5%  
Current ratio x3.43.9 86.9%  
Inventory Days Days410 46.9%  
Debtors Days Days2878 0.2%  
Net fixed assets Rs m3,04145,963 6.6%   
Share capital Rs m213531 40.0%   
"Free" reserves Rs m25,36692,415 27.4%   
Net worth Rs m25,57992,946 27.5%   
Long term debt Rs m00-   
Total assets Rs m38,226113,869 33.6%  
Interest coverage x51.71,270.5 4.1%   
Debt to equity ratio x00-  
Sales to assets ratio x1.10.6 184.2%   
Return on assets %18.517.4 106.3%  
Return on equity %27.021.3 126.5%  
Return on capital %36.928.7 128.6%  
Exports to sales %0.70-   
Imports to sales %12.318.8 65.4%   
Exports (fob) Rs m295NA-   
Imports (cif) Rs m5,30613,127 40.4%   
Fx inflow Rs m35358,877 0.6%   
Fx outflow Rs m5,38913,341 40.4%   
Net fx Rs m-5,03545,536 -11.1%   
CASH FLOW
From Operations Rs m7,26719,469 37.3%  
From Investments Rs m-718751 -95.6%  
From Financial Activity Rs m-5,818-349 1,667.5%  
Net Cashflow Rs m73119,872 3.7%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.0 37.0 18.8%  
FIIs % 0.2 19.3 1.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 48.1 52.0%  
Shareholders   83,236 274,505 30.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Sensex Sheds 427 Points, Nifty Ends Near 17,600; Bajaj Finserv, Tata Steel & Tech Mahindra Top Losers(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

DIVIS LABORATORIES 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of DIVIS LABORATORIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

ABBOTT INDIA Announces Quarterly Results (1QFY22); Net Profit Up 8.5% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 8.5% YoY). Sales on the other hand came in at Rs 12 bn (up 14.4% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

Why Did Shares of Divi's Lab Rally Today? (Views On News)

Jun 10, 2021

The stock jumped 3.6% in intraday trade to hit its 52-week high.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

More Views on News

Most Popular

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jan 21, 2022 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS